DNA

New England Biolabs® Launches EM-seq™ v2, an updated kit for more sensitive detection of 5mC and 5hmC

This bisulfite-free method of methylation detection is updated with a faster, more streamlined workflow that enables highly sensitive methylation analysis…

1 year ago

Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference

JUPITER, Fla., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI),…

1 year ago

Rakovina Therapeutics Announces Receipt of AI-Derived Drug Candidates and Advancement to Preclinical Validation

VANCOUVER, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company focused on the…

1 year ago

Avenues Announces Ribbon-Cutting and Open House of New South Bend Facility

SOUTH BEND, INDIANA / ACCESSWIRE / January 2, 2025 / Avenues Recovery Center announced today the ribbon-cutting ceremony and open…

1 year ago

GCAN to Explore Strategic Alternatives in Artificial Intelligence and Quantum Computing

Company today announced a major strategic step forward as it explores new growth avenuesArtificial Intelligence (AI) and Quantum Computing industries…

1 year ago

Making Cancer Drugs Safer: CellMosaic CEO to Host Live Investment Webinar

DoD-recognized biotech company opens investment round as its cancer treatment technology gains traction with 159+ global organizations. Woburn, MA, Dec.…

1 year ago

U.S. EHR Giants Drive Global Healthcare Digital Transformation Across 39 Countries, 2025 Black Book Reports

Epic, Oracle Health, MEDITECH and Altera Digital Health are redefining healthcare IT worldwide, as highlighted in Black Book research insights…

1 year ago

Recover Red Introduces Portable Red Light Therapy Solution: The Power Stack

Portable, Travel-Friendly Device That Includes Everything You Need For On-The-Go Red Light Therapy. All Neatly Packed Into A Compact 12-Inch…

1 year ago

Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B

– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing observed – – In the…

1 year ago

Matwings Technology Raised Series A Funding of Tens of Millions USD to Redefine Protein Design

'Beyond Structure, Predicting Function' SHANGHAI, Dec. 25, 2024 /PRNewswire/ -- Recently, Shanghai Matwings Technology Co., Ltd. ('Matwings'), a global leader…

1 year ago